Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate‐specific antigen (PSA) level of ≤10 ng/mL and biopsy Gleason score of ≤6, and their influence on PSA progression‐free survival after radical prostatectomy
- 9 May 2006
- journal article
- Published by Wiley in BJU International
- Vol. 97 (6) , 1173-1178
Abstract
OBJECTIVE: To investigate how many men with low‐risk prostate cancer had positive lymph nodes detected by radio‐guided surgery and whether they had a higher biochemical relapse rate after radical prostatectomy, because in such patients most urologists dispense with operative lymph node staging, as nomograms indicate only a low percentage of lymph node metastases. PATIENTS AND METHODS: The study included 474 men with a prostate‐specific antigen (PSA) level of ≤ 10 ng/mL, biopsy Gleason score of ≤ 6 and positive biopsies in one (group 1, 315 men) or both lobes (group 2, 159 men); follow‐up data were available in 357 men. Men with adjuvant radiation or hormone therapy before the occurrence of biochemical relapse were excluded. RESULTS: Positive lymph nodes were detected in 17 men in group 1, and in 18 in group 2. In more than half of the patients (19/35) these nodes were found outside the region of standard lymphadenectomy. Men with node‐positive disease had a higher biochemical relapse rate ( P < 0.001). When the tumour was organ‐confined and well differentiated in node‐positive disease (Gleason score ≤ 6) the biochemical relapse rate was lower than in men with higher tumour stage and grade. CONCLUSIONS: When dissecting pelvic lymph nodes, extended or sentinel lymphadenectomy should be preferred. Removing the diseased nodes could improve the PSA progression‐free survival, especially in well differentiated organ‐confined disease.Keywords
This publication has 26 references indexed in Scilit:
- DETECTION OF EARLY LYMPH NODE METASTASES IN PROSTATE CANCER BY LAPAROSCOPIC RADIOISOTOPE GUIDED SENTINEL LYMPH NODE DISSECTIONJournal of Urology, 2005
- THE EXTENT OF LYMPHADENECTOMY FOR pTXNO PROSTATE CANCER DOES NOT AFFECT PROSTATE CANCER OUTCOME IN THE PROSTATE SPECIFIC ANTIGEN ERAJournal of Urology, 2005
- Is pelvic lymphadenectomy really necessary in patients with a serum prostate‐specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?BJU International, 2005
- Is There a Need for Pelvic Lymph Node Dissection in Low Risk Prostate Cancer Patients Prior to Definitive Local Therapy?European Urology, 2005
- Prostate Lymphoscintigraphy and Radio-Guided Surgery for Sentinel Lymph Node Identification in Prostate CancerUrologia Internationalis, 2003
- Is a Limited Lymph Node Dissection An Adequate Staging Procedure for Prostate Cancer?Journal of Urology, 2002
- Extended Pelvic Lymphadenectomy In Patients Undergoing Radical Prostatectomy: High Incidence Of Lymph Node MetastasisJournal of Urology, 2002
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update1997
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958